Citation tools

Breinholt, Vibeke Miller et al "TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Prodrug, a Potentially Safe and Efficacious New Therapeutic Modality for the Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3–Related Skeletal Dysplasias." Journal of Pharmacology and Experimental Therapeutics 370.3 (2019): 459-471. Web. 24 Sept2023.